Drugstore chain Walgreens Boots Alliance Inc. reported a net loss Thursday, due to a $6.5 billion opioid litigation charge.
Walgreens and rivals CVS Health Corp and Walmart Inc in November last year agreed to pay about $13.8 billion to resolve thousands of U.S. state and local lawsuits accusing the pharmacy chains of mishandling opioid pain drugs.
Walgreens reaffirmed its 2023 adjusted profit of $4.45 per share to $4.65 per share.
Net loss attributable to Walgreens was $3.72 billion, or $4.31 per share, for the quarter ended Nov. 30, compared with a profit of $3.58 billion, or $4.13 per share, a year earlier including a one-time gain of $2.5 billion.
© 2026 Thomson/Reuters. All rights reserved.